Skip to main
CNO
CNO logo

CNO Stock Forecast & Price Target

CNO Analyst Ratings

Based on 5 analyst ratings
Hold
Strong Buy 0%
Buy 40%
Hold 60%
Sell 0%
Strong Sell 0%

Bulls say

CNO Financial Group Inc. exhibited a positive financial trajectory, with life policy income increasing 3.2% year-over-year to $226.5 million, aligning closely with estimates, while overall policy income rose 2.7% to $409.4 million, surpassing forecasts. The company also demonstrated robust growth in its agent count, rising 8.3% year-over-year to 4,952, indicating effective agent recruitment and retention strategies. Additionally, the investment portfolio's book yield improved, reaching 4.87%, alongside a notable increase in collected annuity premiums, which amounted to $493.1 million, reflecting a growing demand for its annuity products.

Bears say

CNO Financial Group's outlook has been negatively impacted by several key financial metrics indicating potential weakness in its performance. The RBC ratio declined slightly to 383%, and there is an expectation of continued declines in fee income for the second consecutive year, primarily due to a shift towards smaller Medicare Advantage providers. Additionally, both the annuity profitability and supplemental health margins have weakened on a year-over-year basis, while the holding company's liquidity decreased to $372 million, further heightening concerns about its financial stability and growth prospects.

CNO has been analyzed by 5 analysts, with a consensus rating of Hold. 0% of analysts recommend a Strong Buy, 40% recommend Buy, 60% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of CNO Financial Group and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About CNO Financial Group (CNO) Forecast

Analysts have given CNO a Hold based on their latest research and market trends.

According to 5 analysts, CNO has a Hold consensus rating as of Oct 14, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $43.60, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $43.60, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

CNO Financial Group (CNO)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.